Skip to content

Thyme Honey for Management of Oral Lichen Planus

Thyme Honey for Management of Oral Lichen Planus: A Non- Inferiority Controlled Randomized Clinical Trial

Status
Enrolling by invitation
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06810752
Enrollment
30
Registered
2025-02-06
Start date
2024-10-12
Completion date
2025-03-31
Last updated
2025-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Lichen Planus

Keywords

Oral Lichen Planus, Thyme Honey, triamcinolone acteonide

Brief summary

the study aimed to assess the effect of topical application of thyme honey in comparison to 0.1% triamcinolone acetonide oral paste on the relief of pain and clinical improvement in patients with OLP

Interventions

DIETARY_SUPPLEMENTthyme honey

Topical application on the oral mucosa

DRUGTriamcinolone Acetonide

Topical application on the oral mucosa

Sponsors

British University In Egypt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

• Patients clinically and histopathologically (if required) diagnosed as suffering from OLP. * Patients free from any visible oral lesions other than OLP. * Patients who agreed to take supplied medications. * Patients who agreed for the biopsy (when required).

Exclusion criteria

• •Patients suffering from any systemic disease. * Treatment with any systemic treatment such as systemic steroids, other immunosuppressive drugs or non-steroidal anti-inflammatory drugs at least eight weeks. * Treatment with any oral topical medications for at least four weeks prior to the study. * Pregnant and lactating women. * In addition, no consideration was given to patients with a history of hypersensitivity to honey.

Design outcomes

Primary

MeasureTime frameDescription
VAS score assessement1 monthPain intensity

Secondary

MeasureTime frame
measurement of salivary level of miRna1551 month

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026